ArticleThe Kaohsiung journal of medical sciences2021

Sorafenib use in hepatitis B virus- or hepatitis C virus-related hepatocellular carcinoma: A propensity score matching study.

Yu-Chi Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.